Competitors’ adoption of analytical facilities and high-potency manufacturing plants
First written in FY2018. 2 of 4 entries say "Worsened", first in FY2019. Latest entry: FY2023.
No other company in this theme has enough history to compare yet.
- FY2023WorsenedAnnual report
「However, competitors are also taking steps to make comparable capital investments and deploy specialized personnel, which could temporarily weaken the Group's competitiveness.」
In addition to the existing risk of competitors following with analytical equipment and construction of similar plants, the company explicitly identifies competitors' deployment of specialized personnel and the possibility of a temporary decline in competitiveness. - FY2021RestatedAnnual report
「However, the Group's competitive advantages could be undermined by competitors' introduction of analytical equipment or construction of similar plants, potentially affecting the Group's operating results and financial condition.」
The company reconfirms the risk of competitors following with analytical equipment and high-potency injectable drug plants. - FY2019WorsenedAnnual report
「Meanwhile, the business environment for contract manufacturing is expected to become more challenging as competitors expand their contract manufacturing businesses in the high-potency pharmaceutical field and new entrants from other industries enter the market.」
In addition to the existing risk of competitors following with analytical equipment and similar plants, the company explicitly identifies expansion by competitors into high-potency contract manufacturing and new entry from other industries. - FY2018First statedAnnual report
「The Group's competitive advantages could be undermined by competitors' introduction of analytical equipment or construction of similar plants, potentially affecting the Group's operating results and financial condition.」
The company positions its analytical capabilities and high-potency injectable drug plant as competitive advantages, while identifying the risk of competitors following suit.